Cita APA (7a ed.)
Yan, L., Deng, Y., Zhou, J., Zhao, H., Wang, G., & Group, C. H. F. A. R. (2018). Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection, 46(3), 385-394.
Cita Chicago Style (17a ed.)
Yan, Linlin, Yongqiong Deng, Jiyuan Zhou, Hong Zhao, Guiqiang Wang, y China Hepb-Related Fibrosis Assessment Research Group. "Serum YKL-40 as a Biomarker for Liver Fibrosis in Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT." Infection 46, no. 3 (2018): 385-394.
Cita MLA (9a ed.)
Yan, Linlin, et al. "Serum YKL-40 as a Biomarker for Liver Fibrosis in Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT." Infection, vol. 46, no. 3, 2018, pp. 385-394.
Precaución: Estas citas no son 100% exactas.